Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

The Carlyle Group continues to reduce its stake in QuidelOrtho Corp, selling shares through a pre-arranged 10b5-1 trading plan.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), has reported the sale of common stock.
• The sales occurred on June 21 and June 24, 2024.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• A total of 142,393 shares were sold across multiple transactions at varying prices.
• The weighted average sale prices ranged from $33.9402 to $35.1464 per share.
• Following these transactions, the Carlyle Group's indirect beneficial ownership is approximately 11,766,022 shares.
• The shares are held of record by Carlyle Partners VI Cayman Holdings, L.P.
• The Carlyle Group Inc. and several related entities may be deemed to share beneficial ownership but disclaim it.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting share sales. It doesn't convey any explicit positive or negative sentiment about the company's performance or future prospects. The sales are part of a pre-arranged plan.

Industry Context

Sales by large shareholders like Carlyle Group are common and can be part of portfolio management strategies. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on current market conditions or inside information.

Stakeholder Impact

• The sale of shares by a major shareholder could create short-term selling pressure on the stock.
• However, the existence of a 10b5-1 plan suggests the sales are orderly and pre-planned, potentially mitigating the impact.

Key Dates